These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30324459)

  • 1. High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease.
    Makishima K; Obara N; Ishitsuka K; Sukegawa S; Suma S; Kiyoki Y; Baba N; Sakamoto T; Kato T; Kusakabe M; Nishikii H; Kurita N; Yokoyama Y; Sakata-Yanagimoto M; Hasegawa Y; Chiba S
    Ann Hematol; 2019 Apr; 98(4):1031-1032. PubMed ID: 30324459
    [No Abstract]   [Full Text] [Related]  

  • 2. How I treat cold agglutinin hemolytic anemia.
    Gertz MA
    Clin Adv Hematol Oncol; 2019 Jun; 17(6):338-343. PubMed ID: 31437137
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term response of refractory primary cold agglutinin disease to eculizumab therapy.
    Gupta N; Wang ES
    Ann Hematol; 2014 Feb; 93(2):343-4. PubMed ID: 23722501
    [No Abstract]   [Full Text] [Related]  

  • 4. Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial.
    Röth A; Bommer M; Hüttmann A; Herich-Terhürne D; Kuklik N; Rekowski J; Lenz V; Schrezenmeier H; Dührsen U
    Blood Adv; 2018 Oct; 2(19):2543-2549. PubMed ID: 30291112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune hemolytic anemia caused by cold agglutinins in a young pregnant woman.
    Batalias L; Trakakis E; Loghis C; Salabasis C; Simeonidis G; Karanikolopoulos P; Kassanos D; Salamalekis E
    J Matern Fetal Neonatal Med; 2006 Apr; 19(4):251-3. PubMed ID: 16854701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
    Feng Q; Zak D; Daya R
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):270-6. PubMed ID: 22706493
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic use of eculizumab during surgery in chronic cold agglutinin disease.
    Tjønnfjord E; Vengen ØA; Berentsen S; Tjønnfjord GE
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28487302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
    Gueli A; Gottardi D; Hu H; Ricca I; De Crescenzo A; Tarella C
    Blood Transfus; 2013 Apr; 11(2):311-4. PubMed ID: 23399352
    [No Abstract]   [Full Text] [Related]  

  • 9. Cold agglutinin disease: an unusual cause of shock in the ICU.
    Al-Dorzi HM; Salama H; Almugairi A; Arabi YM
    Intensive Care Med; 2017 Jun; 43(6):927-928. PubMed ID: 28116450
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease.
    Röth A; Hüttmann A; Rother RP; Dührsen U; Philipp T
    Blood; 2009 Apr; 113(16):3885-6. PubMed ID: 19372265
    [No Abstract]   [Full Text] [Related]  

  • 11. Biphasic hemolysin hemolytic anemia: reappraisal of an acute immune hemolytic anemia of infancy and childhood.
    Sabio H; Jones D; McKie VC
    Am J Hematol; 1992 Mar; 39(3):220-2. PubMed ID: 1546718
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of cold agglutinin immune hemolytic anemia in pregnancy.
    Dhingra S; Wiener JJ; Jackson H
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):485-6. PubMed ID: 17666637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.
    Berentsen S; Tjønnfjord GE
    Blood Rev; 2012 May; 26(3):107-15. PubMed ID: 22330255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fulminant autoimmune cold-type hemolysis with marked elevation of monothermic cold agglutinins. Successful therapy with membrane plasmapheresis].
    Gordjani N; Kretschmer V; Töllner U; Rieger C
    Monatsschr Kinderheilkd; 1990 Aug; 138(8):454-6. PubMed ID: 2215510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hemolytic anemia: classification and therapeutic approaches.
    Sève P; Philippe P; Dufour JF; Broussolle C; Michel M
    Expert Rev Hematol; 2008 Dec; 1(2):189-204. PubMed ID: 21082924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell transfusion in autoimmune hemolytic anemia.
    Buetens OW; Ness PM
    Curr Opin Hematol; 2003 Nov; 10(6):429-33. PubMed ID: 14564173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of cold agglutinin disease.
    Broome CM
    Clin Adv Hematol Oncol; 2019 Mar; 17(3):162-165. PubMed ID: 30969954
    [No Abstract]   [Full Text] [Related]  

  • 18. Remission of cold hemagglutinin disease induced by rituximab therapy.
    Sparling TG; Andricevic M; Wass H
    CMAJ; 2001 May; 164(10):1405. PubMed ID: 11387905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serological characteristics and transfusion efficacy evaluation in 61 cases of autoimmune hemolytic anemia].
    Yu Y; Sun XL; Ma CY; Guan XZ; Zhang XJ; Chen LF; Wang K; Luo YY; Wang Y; Li MW; Feng YN; Tong S; Yu S; Yang L; Wu YQ; Zhuang Y; Pan JC; Fen Q; Zhang T; Wang DQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1275-9. PubMed ID: 24156449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold agglutinin-induced hemolytic anemia during room temperature fluid resuscitation: a case report.
    Kawai Y; Deguchi M; Mizouchi N; Yoshida S; Kumagai K; Hirose Y
    J Med Case Rep; 2021 Apr; 15(1):169. PubMed ID: 33858500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.